• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Quality of Care in Patients With Newly Diagnosed Glaucoma.新诊断青光眼患者的医疗质量
JAMA Ophthalmol. 2025 Sep 18. doi: 10.1001/jamaophthalmol.2025.2995.
2
Device-modified trabeculectomy for glaucoma.用于青光眼的设备改良小梁切除术
Cochrane Database Syst Rev. 2015 Dec 1;2015(12):CD010472. doi: 10.1002/14651858.CD010472.pub2.
3
Multifaceted behavioral interventions to improve topical glaucoma therapy adherence in adults.多方面行为干预以提高成人局部青光眼治疗的依从性。
Cochrane Database Syst Rev. 2025 Jun 11;6(6):CD015788. doi: 10.1002/14651858.CD015788.pub2.
4
Loss to Follow-Up and Risk of Incident Blindness among Patients with Glaucoma in the IRIS® Registry.IRIS® 注册研究中青光眼患者的失访情况及失明风险
Ophthalmol Glaucoma. 2025 May 8. doi: 10.1016/j.ogla.2025.05.001.
5
Fornix-based versus limbal-based conjunctival trabeculectomy flaps for glaucoma.用于青光眼的穹窿部结膜小梁切除术瓣与角膜缘部结膜小梁切除术瓣对比
Cochrane Database Syst Rev. 2015 Nov 25;11(11):CD009380. doi: 10.1002/14651858.CD009380.pub2.
6
Rho kinase inhibitor for primary open-angle glaucoma and ocular hypertension.Rho 激酶抑制剂治疗原发性开角型青光眼和高眼压症。
Cochrane Database Syst Rev. 2022 Jun 10;6(6):CD013817. doi: 10.1002/14651858.CD013817.pub2.
7
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
8
Cyclodestructive procedures for non-refractory glaucoma.非难治性青光眼的睫状体破坏手术
Cochrane Database Syst Rev. 2018 Apr 25;4(4):CD009313. doi: 10.1002/14651858.CD009313.pub2.
9
Peripheral iridotomy for pigmentary glaucoma.色素性青光眼的周边虹膜切开术
Cochrane Database Syst Rev. 2016 Feb 12;2(2):CD005655. doi: 10.1002/14651858.CD005655.pub2.
10
Combined surgery versus cataract surgery alone for eyes with cataract and glaucoma.白内障合并青光眼患者联合手术与单纯白内障手术的比较
Cochrane Database Syst Rev. 2015 Jul 14;2015(7):CD008671. doi: 10.1002/14651858.CD008671.pub3.

本文引用的文献

1
Association of Eye Drop-Treated Diseases and Conditions That Can Impair Eye Drop Self-Administration.滴眼液治疗的疾病与可能损害滴眼液自我给药能力的病症之间的关联。
Ophthalmol Glaucoma. 2025 Apr 8. doi: 10.1016/j.ogla.2025.04.001.
2
Race, Social Determinants of Health, and the Quality of Diabetic Eye Care.种族、健康的社会决定因素与糖尿病眼病护理质量。
JAMA Ophthalmol. 2024 Oct 1;142(10):961-970. doi: 10.1001/jamaophthalmol.2024.3528.
3
Loss to Follow Up Among Glaucoma Patients: An IRIS® Registry (Intelligent Research in Sight) Retrospective Cohort Analysis.青光眼患者的失访情况:一项IRIS®注册研究(视力智能研究)回顾性队列分析。
Semin Ophthalmol. 2025 Apr;40(3):188-195. doi: 10.1080/08820538.2024.2391826. Epub 2024 Aug 16.
4
Factors Associated with Nonreturn after Loss to Follow-Up from Glaucoma Care: An IRIS® Registry Retrospective Analysis.与青光眼护理随访失访后不回诊相关的因素:IRIS® 注册回顾性分析。
Ophthalmol Glaucoma. 2024 Nov-Dec;7(6):572-579. doi: 10.1016/j.ogla.2024.07.007. Epub 2024 Jul 20.
5
Racial Disparities in Glaucoma Vision Outcomes and Eye Care Utilization: An IRIS Registry Analysis.青光眼视力预后和眼保健利用方面的种族差异:一项IRIS注册研究分析。
Am J Ophthalmol. 2024 Aug;264:194-204. doi: 10.1016/j.ajo.2024.03.022. Epub 2024 Mar 27.
6
Social determinants of health and health disparities in glaucoma: A review.社会决定因素与青光眼健康差异:综述。
Clin Exp Ophthalmol. 2024 Apr;52(3):276-293. doi: 10.1111/ceo.14367. Epub 2024 Feb 22.
7
Prediction Models for Glaucoma in a Multicenter Electronic Health Records Consortium: The Sight Outcomes Research Collaborative.多中心电子健康记录联盟中青光眼的预测模型:视力结果研究协作组
Ophthalmol Sci. 2023 Dec 6;4(3):100445. doi: 10.1016/j.xops.2023.100445. eCollection 2024 May-Jun.
8
Social Determinants of Health and Perceived Barriers to Care in Diabetic Retinopathy Screening.社会决定因素与糖尿病视网膜病变筛查中感知到的护理障碍。
JAMA Ophthalmol. 2023 Dec 1;141(12):1161-1171. doi: 10.1001/jamaophthalmol.2023.5287.
9
Factors Affecting Glaucoma Medication Adherence and Interventions to Improve Adherence: A Narrative Review.影响青光眼药物依从性的因素及提高依从性的干预措施:一项叙述性综述
Ophthalmol Ther. 2023 Dec;12(6):2863-2880. doi: 10.1007/s40123-023-00797-8. Epub 2023 Sep 12.
10
A scoping review of patients' barriers to eye care for glaucoma and keratitis.一项针对青光眼和角膜炎患者眼科护理障碍的范围综述。
Surv Ophthalmol. 2023 Jul-Aug;68(4):567-577. doi: 10.1016/j.survophthal.2023.03.005. Epub 2023 Apr 1.

新诊断青光眼患者的医疗质量

Quality of Care in Patients With Newly Diagnosed Glaucoma.

作者信息

Ige Maryam O, French Dustin D, Chaudhury Azraa S, Li Yang, Andrews Chris A, Kanwar Kunal, Zhou Xueqing, Marwah Shikha, Evans Charlesnika T, Kho Abel N, Bryar Paul J, Stein Joshua D

机构信息

Department of Ophthalmology, Northwestern University Feinberg School of Medicine, Chicago, Illinois.

Department of Medical Social Science, Northwestern University Feinberg School of Medicine, Chicago, Illinois.

出版信息

JAMA Ophthalmol. 2025 Sep 18. doi: 10.1001/jamaophthalmol.2025.2995.

DOI:10.1001/jamaophthalmol.2025.2995
PMID:40965904
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12447283/
Abstract

IMPORTANCE

Various communities continue to experience relatively high rates of glaucoma-related visual impairment and blindness. Identifying potential nonmedical influences on glaucoma outcomes may lead to strategies to improve glaucoma care.

OBJECTIVE

To assess possible associations between nonmedical variables and quality of glaucoma care among patients with newly diagnosed primary open-angle glaucoma (POAG).

DESIGN, SETTING, AND PARTICIPANTS: This retrospective cohort study included 1466 patients with newly diagnosed POAG receiving care at health systems in the Sight Outcomes Research Collaborative (SOURCE) Consortium from January 2010 to December 2022. Data analysis was completed from March 2024 to June 2025.

EXPOSURES

Various nonmedical variables, including self-reported race and ethnicity, urbanicity of residence, affluence of patients' residential community, and presence of children in the household.

MAIN OUTCOMES AND MEASURES

The primary outcomes were odds of 15% or greater intraocular pressure (IOP) reduction at 12 to 18 months following initial POAG diagnosis and odds of loss to follow-up (LTFU).

RESULTS

Mean (SD) age of patients was 70 (12) years; among 1466 patients, 793 (54%) were female. By self-reported race and ethnicity, 39 patients (3%) were Asian American, 469 patients (32%) were Black, 95 (7%) were Latinx, and 831 (57%) were White. Among 1030 patients (70%) with 1 or more follow-up evaluations within 12 to 18 months following initial POAG diagnosis, 783 (76%) achieved 15% or higher IOP reduction in 1 or more eyes. Patients in the lowest wealth quartile had 5- to 9-fold lower odds of achieving 15% or greater IOP decrease compared with patients in higher quartiles; the odds of LTFU were 61% lower in the wealthiest patient quartile than in the least-wealthy group (odds ratio [OR], 0.39; 95% CI, 0.18-0.84; P = .02). Patients in rural communities (OR, 5.54; 95% CI, 1.13-27.08) were more likely than urban residents to experience LTFU. Patients with children in the household experienced, on average, a 4-mm Hg (95% CI, 0.99-7.13) greater IOP reduction compared with those without children in the household (P = .01).

CONCLUSIONS AND RELEVANCE

In this cohort study, patients with newly diagnosed POAG in the lowest wealth quartile were substantially less likely to achieve the US National Quality Forum's recommended IOP percentage reduction and considerably more likely to experience LTFU than those with higher wealth levels. These findings support the premise that clinicians should understand financial circumstances of patients when making management decisions and reinforce the need for clinicians and payors to find ways to ensure that patients can access IOP-lowering interventions and receive follow-up care in accordance with established guidelines.

摘要

重要性

不同社区的青光眼相关视力损害和失明发生率仍然相对较高。识别对青光眼治疗结果可能产生的非医学影响,或许能催生改善青光眼护理的策略。

目的

评估新诊断的原发性开角型青光眼(POAG)患者的非医学变量与青光眼护理质量之间可能存在的关联。

设计、设置和参与者:这项回顾性队列研究纳入了2010年1月至2022年12月期间在视力结果研究协作组(SOURCE)联盟的医疗系统接受治疗的1466例新诊断的POAG患者。数据分析于2024年3月至2025年6月完成。

暴露因素

各种非医学变量,包括自我报告的种族和族裔、居住的城市化程度、患者居住社区的富裕程度以及家中是否有孩子。

主要结局和测量指标

主要结局是初次诊断POAG后12至18个月眼压(IOP)降低15%或更多的几率以及失访(LTFU)几率。

结果

患者的平均(标准差)年龄为70(12)岁;在1466例患者中,793例(54%)为女性。根据自我报告的种族和族裔,39例(3%)为亚裔美国人,469例(32%)为黑人,95例(7%)为拉丁裔,831例(57%)为白人。在初次诊断POAG后12至18个月内进行了1次或更多次随访评估的1030例患者(70%)中,783例(76%)的一只或多只眼睛眼压降低了15%或更多。与处于较高财富四分位数的患者相比,处于最低财富四分位数的患者眼压降低15%或更多的几率低5至9倍;最富裕患者四分位数组的失访几率比最不富裕组低61%(优势比[OR],0.39;95%置信区间,0.18 - 0.84;P = 0.02)。农村社区的患者(OR,5.54;95%置信区间,1.13 - 27.08)比城市居民更易出现失访。家中有孩子的患者与家中没有孩子的患者相比,眼压平均降低幅度更大,为4毫米汞柱(95%置信区间,0.99 - 7.13)(P = 0.01)。

结论与意义

在这项队列研究中,与财富水平较高的患者相比,处于最低财富四分位数的新诊断POAG患者实现美国国家质量论坛推荐的眼压降低百分比的可能性大幅降低,且失访的可能性显著更高。这些发现支持了这样一个前提,即临床医生在做出管理决策时应了解患者的经济状况,并强化临床医生和支付方寻找方法以确保患者能够获得降低眼压的干预措施并按照既定指南接受后续护理的必要性。